Imprint

Published by:

Bayer HealthCare AG, Leverkusen, Germany
represented by the Management Board:
Arthur Higgins (Chairman), Werner Baumann, Hartmut Klusik,
Lykele van der Broek, Gunnar Riemann

51368 Leverkusen
Phone: +49 (0)214 30-1
E-Mail: info@bayerhealthcare.com

Entry in the Commercial Register of the Cologne District Court (Amtsgericht): HRB 49894
Turnover tax ID no.: DE 813544759

Edited by:

Bayer HealthCare LLC
P.O. Box 390,
Shawnee Mission, KS 66201-0390
120707 Shawnee Mission Parkway
USA

© Copyright Bayer HealthCare AG, Leverkusen, Germany

close window
Important Risk Information:


Dogs: Ingestion of this product by dogs may cause serious adverse reactions including depression, salivation, dilated pupils, incoordination, panting and generalized muscle tremors. In avermectin-sensitive dogs, the signs may be more severe and may include coma and death. Reduce the risk of accidental oral ingestion by separating treated pets for 30 minutes. Cats: Oral ingestion by cats may result in hypersalivation, tremors, vomiting, and decreased appetite.


Advantage Multi™ for Dogs (imidacloprid + moxidectin) product label >>
Advantage Multi™ for Cats (imidacloprid + moxidectin) product label >>